Analysts Expect Genpact Limited (G) Will Announce Quarterly Sales of $685.95 Million
Wall Street analysts predict that Genpact Limited (NYSE:G) will announce sales of $685.95 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Genpact Limited’s earnings, with the lowest sales estimate coming in at $682.14 million and the highest estimate coming in at $691.85 million. Genpact Limited posted sales of $648.78 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 5.7%. The firm is scheduled to report its next earnings results after the market closes on Tuesday, November 7th.
On average, analysts expect that Genpact Limited will report full year sales of $685.95 million for the current fiscal year, with estimates ranging from $2.67 billion to $2.71 billion. For the next financial year, analysts expect that the firm will report sales of $2.87 billion per share, with estimates ranging from $2.81 billion to $2.92 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that cover Genpact Limited.
Genpact Limited (NYSE:G) last issued its earnings results on Wednesday, August 2nd. The business services provider reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.10. The business had revenue of $670.70 million for the quarter, compared to analysts’ expectations of $642.68 million. Genpact Limited had a net margin of 10.22% and a return on equity of 23.33%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.36 EPS.
Several equities research analysts have commented on G shares. Zacks Investment Research lowered shares of Genpact Limited from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Deutsche Bank AG boosted their target price on shares of Genpact Limited from $26.00 to $28.00 and gave the stock a “hold” rating in a research report on Thursday, August 3rd. BMO Capital Markets boosted their target price on shares of Genpact Limited from $26.00 to $30.00 and gave the stock a “market perform” rating in a research report on Thursday, August 3rd. Wedbush initiated coverage on shares of Genpact Limited in a research report on Thursday, August 3rd. They set a “neutral” rating and a $33.00 target price on the stock. Finally, Cowen and Company reaffirmed an “outperform” rating and set a $33.00 price target (up previously from $30.00) on shares of Genpact Limited in a research note on Thursday, August 3rd. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $32.38.
In related news, insider Piyush Mehta sold 20,728 shares of the business’s stock in a transaction dated Thursday, October 26th. The shares were sold at an average price of $30.00, for a total value of $621,840.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amit Chandra sold 275,508 shares of the company’s stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $28.72, for a total transaction of $7,912,589.76. The disclosure for this sale can be found here. Insiders have sold a total of 10,379,170 shares of company stock valued at $298,097,116 in the last ninety days. Corporate insiders own 1.41% of the company’s stock.
Several large investors have recently modified their holdings of the company. YorkBridge Wealth Partners LLC boosted its holdings in Genpact Limited by 5.2% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 3,793 shares of the business services provider’s stock worth $106,000 after acquiring an additional 189 shares during the period. SG Americas Securities LLC purchased a new position in shares of Genpact Limited during the 1st quarter valued at approximately $110,000. Acrospire Investment Management LLC boosted its stake in shares of Genpact Limited by 569.8% during the 2nd quarter. Acrospire Investment Management LLC now owns 4,019 shares of the business services provider’s stock valued at $112,000 after buying an additional 3,419 shares during the last quarter. Meeder Asset Management Inc. acquired a new stake in shares of Genpact Limited during the 3rd quarter valued at approximately $128,000. Finally, Bronfman E.L. Rothschild L.P. raised its position in shares of Genpact Limited by 1.9% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 5,053 shares of the business services provider’s stock valued at $141,000 after acquiring an additional 94 shares in the last quarter. Institutional investors and hedge funds own 92.50% of the company’s stock.
Genpact Limited (G) opened at $30.24 on Friday. The stock has a market cap of $5.84 billion, a P/E ratio of 20.59, a price-to-earnings-growth ratio of 2.11 and a beta of 0.58. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.82.
About Genpact Limited
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with MarketBeat.com's FREE daily email newsletter.